Best Cll Podcasts (2025)

1
Presented at ASH 2025: EPCORE CLL-1 trial on epcoritamab monotherapy for Richter transformation 14:22

Play Pause

4h ago14:22

14:22

Arnon Kater joins Daniela Marin of The Lancet Haematology to discuss the phase 1b/2 EPCORE CLL-1 trial of epcoritamab monotherapy for Richter transformation, which is being presented at ASH 2025. Click here to read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00327-8/fulltext Continue this conversation on soc…

1
CLL17 Trial Insights: Fixed-Duration vs Continuous Therapy in Frontline CLL 4:00

23h ago4:00

4:00

Guest: Ryan Quigley At the 2025 American Society of Hematology Annual Meeting and Exposition, researchers presented key findings from the pivotal phase three CLL17 trial, which was the first randomized study to directly compare continuous BTK inhibition with fixed-duration venetoclax-based therapy in previously untreated chronic lymphocytic leukemi…

1
Double-Exposed CLL/SLL: A Canadian Perspective 22:52

6d ago22:52

22:52

In this episode with Dr Robert Puckrin, we discuss the unmet needs of double-exposed patients with CLL/SLL, as well as the current and novel treatments that can address this gap. Our guest Dr. Puckrin is a Hematologist and Clinician Investigator at the Arthur Child Comprehensive Cancer Centre and Alberta Blood and Marrow Transplant Program. He is a…

1
Episode 35: How Best to Treat CLL Upfront? 11:52

7d ago11:52

11:52

Dr. Mazyar Shadman joined Healthcare Unfiltered EXPRESS to share his insights on data-driven approaches to treating CLL in the front-line setting. Timely podcast as we approach the annual ASH 2025 meeting. Check it out, subscribe, and join the conversation.By Chadi Nabhan

1
New Research: Mitochondrial DNA in TRALI and Venetoclax-Obinituzumab in CLL Trials 18:36

26d ago18:36

18:36

In this week's episode, associate editor Dr. James Griffin interviews researchers Dr. John Semple and Dr. Othman Al-Sawaf on their groundbreaking studies on transfusion-related acute lung injury and chronic lymphocytic leukemia treatment. Dr. Semple explored how mitochondrial DNA could act as a first hit in lung injury, while Dr. Al-Sawaf revealed …

1
CLL17 Trial Insights: Fixed-Duration vs Continuous Therapy in Frontline CLL 4:00

23h ago4:00

4:00

Guest: Ryan Quigley At the 2025 American Society of Hematology Annual Meeting and Exposition, researchers presented key findings from the pivotal phase three CLL17 trial, which was the first randomized study to directly compare continuous BTK inhibition with fixed-duration venetoclax-based therapy in previously untreated chronic lymphocytic leukemi…

1
Episode 36: Curbside Consults in the Age of AI 21:08

5h ago21:08

21:08

I am joined by Dr. Erica Conroy, CEO of Primm.co, and Dr. Matt Kurian, a breast medical oncologist. They both share the importance of curbside consults between oncologists at the point of care. Erica leads an innovative company that allows exchange of ideas, opinions, and aid to healthcare professionals to navigate the complexity of medical oncolog…

1
Sunday Solace: Mindset Reset ~ Why What YOU Focus on Grows 9:41

5h ago9:41

9:41

Send us a text Hey y’all, welcome to Sunday Solace here on Grit, Grace & Transformation and soon to be Midlife Renewal, a podcast for the woman navigating change, craving clarity, and longing to feel grounded in her mind, body, and soul. Men ~ you’re also welcome! I’m Rachael, your Host and Incite Transformation Life Coach. Go ahead and grab your c…

1
Special Episode: Maternal Health in Hematology 20:47

2h ago20:47

20:47

In this special episode, Blood editor Dr. Laura Michaelis interviews Dr. Arielle Langer and Blood Associate editor Dr. Marc Blondon for this special Maternal Health episode. In honor of the second Maternal Health compendium, both discuss their papers featured in this special collection. Featured Articles: β-Thalassemia minor is associated with high…

1
Susana Banerjee, MBBS, MA, FRCP, PhD, Ana Oaknin, MD, PhD - Putting the Puzzle Together in Advanced Ovarian and Cervical Cancers: Translating Evidence Into Practice for Approved and Emerging ADCs 36:50

4d ago36:50

36:50

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/WMS865. EBAC/CME c…

1
Susana Banerjee, MBBS, MA, FRCP, PhD, Ana Oaknin, MD, PhD - Putting the Puzzle Together in Advanced Ovarian and Cervical Cancers: Translating Evidence Into Practice for Approved and Emerging ADCs 36:50

4d ago36:50

36:50

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete EBAC/CME information, and to apply for credit, please visit us at PeerView.com/WMS865. EBAC/CME c…

1
Winning Strategies for Cruise Ship Gambling with Kay Branson 30:29

1h ago30:29

30:29

Send us a text Winning Strategies for Cruise Ship Gambling with Kay Branson In this episode of Open Forum in The Villages, Florida, host Mike Roth welcomes retired marketing executive Kay Branson. Kay shares her extensive experience and strategies for successful gambling on cruise ships. She discusses her background in gambling, starting from child…

1
Analysis of IELSG37 Trial Results and PF4 in Stem Cell Aging 16:14

5d ago16:14

16:14

In this week's episode, Blood editor Dr. James Griffin speaks with Drs. Emanuele Zucca and Sandra Pinho about their latest articles published in Blood. Dr. Zucca discusses his second analysis of the IELSG37 trial, where findings suggested that R-CHOP21 rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, administered every 21 days…

1
Erica L. Mayer, MD, MPH - Nurturing Lasting Benefits of Adjuvant CDK4/6 Inhibitor Therapy in High-Risk HR+, HER2- EBC: Best Practices for Patient Education, AE Monitoring and Management, and Enhanced Adherence ... 22:27

5d ago22:27

22:27

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…

1
Erica L. Mayer, MD, MPH - Risk Assessment and Treatment Initiation: Successfully Jumpstarting the Adjuvant CDK4/6 Inhibitor Treatment Journey in HR+, HER2- EBC 26:40

5d ago26:40

26:40

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…

1
Angela Lamarca, MD, PhD, MSc - The Power of Personalised Approaches in Advanced CCA: Team-Based Strategies to Individualise Clinical Care 35:00

5d ago35:00

35:00

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/NJR865. CME credit will…

1
Susana Banerjee, MBBS, MA, FRCP, PhD, Kathleen N. Moore, MD, MS - Harnessing the Power of ADCs in Gynecologic Cancers: Expert Insights for Practice Integration 38:01

5d ago38:01

38:01

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAD865. CME/MO…

1
Erica L. Mayer, MD, MPH - Nurturing Lasting Benefits of Adjuvant CDK4/6 Inhibitor Therapy in High-Risk HR+, HER2- EBC: Best Practices for Patient Education, AE Monitoring and Management, and Enhanced Adherence ... 22:27

5d ago22:27

22:27

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…

1
Angela Lamarca, MD, PhD, MSc - The Power of Personalised Approaches in Advanced CCA: Team-Based Strategies to Individualise Clinical Care 35:00

2d ago35:00

35:00

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/NJR865. CME credit will…

1
Erica L. Mayer, MD, MPH - Risk Assessment and Treatment Initiation: Successfully Jumpstarting the Adjuvant CDK4/6 Inhibitor Treatment Journey in HR+, HER2- EBC 26:40

5d ago26:40

26:40

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/…

1
Professor Stephen Johnston, MA, FRCP, PhD - Charting New Paths in the Treatment of ER+, HER2- MBC: Seeking Clarity and Consensus Through Evidence-Aligned Clinical Cases 1:10:49

5d ago1:10:49

1:10:49

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView…

1
Professor Stephen Johnston, MA, FRCP, PhD - Charting New Paths in the Treatment of ER+, HER2- MBC: Seeking Clarity and Consensus Through Evidence-Aligned Clinical Cases 1:10:57

5d ago1:10:57

1:10:57

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/EBAC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView…

1
Susana Banerjee, MBBS, MA, FRCP, PhD, Kathleen N. Moore, MD, MS - Harnessing the Power of ADCs in Gynecologic Cancers: Expert Insights for Practice Integration 38:01

5d ago38:01

38:01

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/UAD865. CME/MO…

1
ASH 2025 Preview - Expert Roundtable 22:12

3d ago22:12

22:12

Khaled Musallam, Bethany Samuelson Bannow, Mohamad Mohty, David Sallman, and Anna Sureda join us to share their expectations for the upcoming ASH 2025 congress, to be held from 6 to 9 December 2025 in Orlando, on classical and malignant haematology. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://i…

1
Arnon Kater and Sabina Kersting on the HOVON 158/NEXT STEP phase 2 trial testing a new first-line treatment regimen for chronic lymphocytic leukaemia 24:24

3d ago24:24

24:24

Professor Arnon Kater and Dr Sabina Kersting join us to discuss the results of their phase 2 trial testing a new first-line treatment regimen in chronic lymphocytic leukaemia: fixed-duration ibrutinib–venetoclax followed by MRD-guided ibrutinib–obinutuzumab intensification. Click here to read the full article: https://www.thelancet.com/journals/lan…

1
Episode 34: Managing T-Cell Lymphomas in 2025-2026 14:27

7d ago14:27

14:27

Dr. Matt Lunning from the University of Nebraska simplifies how best we approach these aggressive diverse collections of lymphomas. Concise and straight to the point; check it out, subscribe, and join the conversation.By Chadi Nabhan

1
Sunday Solace: “Start Your Christmas Season with Peace, Presence & Wonder” 8:14

9d ago8:14

8:14

Send us a text Good morning, y'all … welcome to another episode of Sunday Solace. I’m your host, Rachael & It’s the Sunday after Thanksgiving ~ the world is already shifting. Leftover goodies still in the fridge, and y’all will have to message me and let me know some of things that you made with the leftovers. I have heard of potato cakes the next …

1
The Legal Landscape of Florida: A Conversation with Judge Takac 27:09

7d ago27:09

27:09

Send us a text The Legal Landscape of Florida: A Conversation with Judge Takac Judge Michael Takac: Insights from the Bench in The Villages In this episode of Open Forum in The Villages, host Mike Roth sits down with Judge Michael Takac of the Fifth Circuit Court of Florida. They discuss the various aspects of the circuit court system, what kinds o…

1
Fixed-Duration Epcoritamab Combination Therapy for Relapsed or Refractory Follicular Lymphoma and Pre-Transplant Strategies for GVHD post-HSCT 22:01

12d ago22:01

22:01

In this week's episode, Blood editor Dr. Laurie Sehn interviews authors Drs. Lorenzo Falchi and Robert Levy on their latest papers published in Blood Journal. Dr. Falchi discusses his work on an open-label, multicenter phase 1b/2 study evaluating fixed-duration epcoritamab with rituximab and lenalidomide in 108 patients with relapsed or refractory …

1
Sickle cell disease management: navigating the transition from pediatric to adult care, managing VOCs, & more 18:49

8d ago18:49

18:49

In this podcast episode, leading experts provide valuable insight into the management of sickle cell disease (SCD). First, Samah Babiker, MBBS, MRCP-UK, FRCPath, Evelina London Children’s Hospital, London, UK, and Payal Desai, MD, Levine Cancer Institute & Wake Forest School of Medicine, Charlotte, NC, discuss the challenges associated with the tra…

1
Choose Presence Over Pressure This Thanksgiving Day 8:58

10d ago8:58

8:58

Send us a text Good morning, y’all… and Happy Thanksgiving. I’m your host, Rachael & I know how busy today gets. But right here, right now… let’s create a little sanctuary together. Before the turkey goes in the oven… Before the house wakes up… Before the tablecloth is ironed and the mashed potatoes start flying… grab your coffee and your water wit…

1
Sunday Solace: Sacred Side Dishes of Thanksgiving 13:49

14d ago13:49

13:49

Send us a text Good morning, friends, and welcome to another episode of Sunday Solace. I’m your host, Rachael, and as we enter Thanksgiving week here in the United States — Oh My Stars — my heart is full. This is one of my favorite weeks of the year. There is something about the rhythm of slowing down, cooking with our hands, gathering around table…

1
Episode 33: New Targets in Breast Cancer 18:53

16d ago18:53

18:53

Dr. Matthew Kurian joins Healthcare Unfiltered EXPRESS to share his observations and insights on new emerging targets in breast cancer and how these targets are driving treatment selection across all disease stages. Please subscribe, review, and join the conversation.By Chadi Nabhan

1
Exploring the 2026 Maker Faire Orlando: A Journey Beyond The Villages 18:19

15d ago18:19

18:19

Send us a text Exploring the Maker's Fair in Orlando Welcome to Season seven of Open Forum in The Villages Florida, hosted by Mike Roth. In this solo episode, Mike shares his recent experience at the Maker's Fair in Orlando, Florida. He discusses various exhibits and activities, such as learning to solder, making t-shirts, robot battle zones, and t…

1
Rethinking Hormones: Testosterone and Estrogen in Women’s Heart Health 4:45

18d ago4:45

4:45

Guest: Susan Davis Emerging research is challenging long-held assumptions about the roles of estrogen and testosterone in women’s health—particularly in the context of aging and cardiometabolic risk. Hear from Dr. Susan Davis as she reviews the evolving evidence. Dr. Davis is an endocrinologist as well as the head of the Women’s Health Research Pro…

1
Targeting Vascular KCNQ5 Channels: A Promising Strategy for Blood Pressure Control 4:45

18d ago4:45

4:45

A recent study explored the emerging role of KCNQ5 potassium channels in vascular smooth muscle regulation and their potential as therapeutic targets to promote vasodilation and manage blood pressure. Hear from Dr. Geoffrey Abbott as he dives into cutting-edge research using a CRISPR-generated KCNQ5 knockout rat model, revealing critical insights i…

1
Navigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control 3:15

18d ago3:15

3:15

Guest: Jun-ichi Abe, MD, PhD Cancer therapies can trigger both acute and chronic vascular effects, from treatment-induced hypertension to long-term atherosclerotic changes. Learn more as Dr. Jun-ichi Abe shares insights from his presentation at the 2025 American Heart Association Scientific Sessions. Dr. Abe is a Professor in the Department of Card…

1
Yelena Y. Janjigian, MD*, Siva Raja, MD, PhD, FACS - Critical Conversations for Surgeons and Oncologists in Resectable Gastric/GEJ Cancer: Expert Guidance on Integrating Rapidly Evolving Evidence for Immunotherapy ... 49:48

18d ago49:48

49:48

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/ZSR865. CME/AAPA c…

1
Yelena Y. Janjigian, MD*, Siva Raja, MD, PhD, FACS - Critical Conversations for Surgeons and Oncologists in Resectable Gastric/GEJ Cancer: Expert Guidance on Integrating Rapidly Evolving Evidence for Immunotherapy ... 49:48

18d ago49:48

49:48

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/ZSR865. CME/AAPA c…

1
Advancing Blood Disorder Treatments Through Precision Therapeutics 15:08

19d ago15:08

15:08

In this week's episode, Blood editor Dr. Laura Michaelis interviews authors Drs. Terri Parker and Peter Lenting on their latest papers published in Blood Journal. Dr. Lenting discusses his work on introducing a new therapeutic approach to von Willebrand disease with the development of a novel bispecific antibody (KB-V13A12) that links endogenous mo…

1
Accelerated- and blast-phase MPNs: diagnosis, management, and current challenges 18:53

15d ago18:53

18:53

This episode of the VJHemOnc podcast focuses on accelerated and blast-phase myeloproliferative neoplasms (MPN-AP/BP), offering insights into their diagnosis and management from leading experts. First, in an interview with Anand Patel, MD, University of Chicago Medical Center, Chicago, IL, you will hear about the diagnosis, risk stratification, and …

1
Is Fixed Duration Therapy the New Standard? 24:46

18d ago24:46

24:46

Patient advocate, Michele Nadeem Baker, hosts Boyu Hu, MD, Director of Lymphoma and Chronic Lymphocytic Leukemia at the Huntsman Cancer Institute at the University of Utah for a discussion on fixed duration treatment.By Patient Power

1
Episode 32: Bringing Scientific Progress to LMIC 18:42

18d ago18:42

18:42

Dr. Karima Oualla joins the show to share how she brings research studies and scientific progress to clinical practice in Morocco. Despite limited resources, Dr. Oualla has pioneered research and cutting edge clinical care in her home country. Please subscribe, share, and join the conversation.By Chadi Nabhan

1
TROP2 and TIGIT Therapies for Advanced NSCLC: Where Are We Today? 20:37

20d ago20:37

20:37

In this episode, Benjamin Levy, MD, FASCO, and Alex Spira, MD, PhD, FASCO, discuss the latest developments in targeting TROP2 and TIGIT for the treatment of lung cancer, including: TROP2-targeting ADCs: datopotamab deruxtecan, sacituzumab govitecan, sacituzumab tirumotecan TROP2 ADCS for patients with EGFR-mutated NSCLC TIGIT-targeting agents: domv…

1
Episode 31: Tumor-Agnostic Therapies 21:17

20d ago21:17

21:17

Should we treat cancers regardless of where they had originated from? Dr. Vivek Subbiah, world-renowned oncologist and researcher, joined Healthcare Unfiltered EXPRESS to advocate that this is the way of the future. A must listen episode looking into the future of cancer therapeutics. Please subscribe, share, and join the conversation.…

1
Episode 30: New Treatment for Refractory Colorectal Cancers 17:30

23d ago17:30

17:30

Dr. Anwaar Saeed joined Healthcare Unfiltered EXPRESS to discuss her recent paper published in The Lancet that addressed treating metastatic refractory colorectal cancers. Please share your thoughts and subscribe.By Chadi Nabhan

1
A Tale of Two Ships and Planes 28:50

22d ago28:50

28:50

Send us a text A Tale of Two Ships and a Plane - An Adventure Across Barcelona, Marseilles, and Beyond In this solo episode of Season 7 of Open Forum in the Villages, Florida, Mike Roth shares an in-depth recount of his recent vacation travels. The trip begins with a smooth experience on Air Canada from Orlando to Barcelona, offering high praise fo…

1
The value and utility of MRD in the management of adults with newly-diagnosed AML 16:25

21d ago16:25

16:25

This podcast features experts Mark Levis, MD, PhD, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, Sanam Loghavi, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, and Eunice Wang, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, who debate the value and utility of measurable residual disease (MRD) in the manag…

1
Episode 29: Updates on Prostate Cancer from ESMO 2025 18:04

28d ago18:04

18:04

Dr. Karine Tawagi joins the show to detail prostate cancer data from ESMO 2025 that carries the most important clinical implications. What trial data mattered the most? Take a listen and join the conversation.By Chadi Nabhan

1
Episode 28: What is New in Kidney Cancer Treatments? 12:30

27d ago12:30

12:30

From Madrid, Dr. Enrique Grande joins Healthcare Unfiltered EXPRESS to share his thoughts and insights on data pertaining to renal cancer from the latest ESMO 2025 meeting. A 13-minutes that is worth your time. Please subscribe and join the conversation.By Chadi Nabhan